Authors:
LOWENBERG B
SUCIU S
ARCHIMBAUD E
HAAK H
STRYCKMANS P
DECATALDO R
DEKKER AW
BERNEMAN ZN
THYSS A
VANDERLELIE J
SONNEVELD P
VISANI G
FILLET G
HAYAT M
HAGEMEIJER A
SOLBU G
ZITTOUN R
Citation: B. Lowenberg et al., MITOXANTRONE VERSUS DAUNORUBICIN IN INDUCTION-CONSOLIDATION CHEMOTHERAPY - THE VALUE OF LOW-DOSE CYTARABINE FOR MAINTENANCE OF REMISSION, AND AN ASSESSMENT OF PROGNOSTIC FACTORS IN ACUTE MYELOID-LEUKEMIA IN THE ELDERLY - FINAL REPORT OF THE LEUKEMIA COOPERATIVE GROUP OF THE ANIZATION-FOR-THE-RESEARCH-AND-TREATMENT-OF-CANCER AND THE DUTCH-BELGIAN HEMATOONCOLOGY COOPERATIVE HOVON GROUP RANDOMIZED PHASE-III STUDY AML-9, Journal of clinical oncology, 16(3), 1998, pp. 872-881
Authors:
DECAUDIN D
BOSQ J
TERTIAN G
NEDELLEC G
BENNACEUR A
VENUAT AM
BAYLE C
CARDE P
BENDAHMANE B
HAYAT M
MUNCK JN
Citation: D. Decaudin et al., PHASE-II TRIAL OF FLUDARABINE MONOPHOSPHATE IN PATIENTS WITH MANTLE-CELL LYMPHOMAS, Journal of clinical oncology, 16(2), 1998, pp. 579-583
Authors:
RIBRAG V
NASR F
BOUHRIS JH
BOSQ J
BRAULT P
GIRINSKY T
COSSET JM
MUNCK JN
CORTI C
DECAUDIN D
PICO JL
HAYAT M
CARDE P
Citation: V. Ribrag et al., VIP (ETOPOSIDE, IFOSFAMIDE AND CISPLATINUM) AS A SALVAGE INTENSIFICATION PROGRAM IN RELAPSED OR REFRACTORY HODGKINS-DISEASE, Bone marrow transplantation, 21(10), 1998, pp. 969-974
Authors:
HAYAT M
EVERETT S
WHITE K
DRAKE I
OMAHONY S
Citation: M. Hayat et al., ASCORBIC-ACID AND TOTAL VITAMIN-C CONCENTRATIONS IN PLASMA, GASTRIC-JUICE, AND GASTROINTESTINAL MUCOSA IN LYMPHOCYTIC GASTRITIS, Gastroenterology, 114(4), 1998, pp. 600-600
Citation: M. Hayat et al., THE EFFECTS OF HELICOBACTER-PYLORI ERADICATION ON THE NATURAL-HISTORYOF LYMPHOCYTIC GASTRITIS, Gastroenterology, 114(4), 1998, pp. 601-601
Authors:
KEATING S
DEWITTE T
SUCIU S
WILLEMZE R
HAYAT M
LABAR B
RESEGOTTI L
FERRINI PR
CARONIA F
DARDENNE M
SOLBU G
PETTI MC
VEGNA ML
MANDELLI F
ZITTOUN RA
Citation: S. Keating et al., THE INFLUENCE OF HLA-MATCHED SIBLING DONOR AVAILABILITY ON TREATMENT OUTCOME FOR PATIENTS WITH AML - AN ANALYSIS OF THE AML 8A STUDY OF THEEORTC-LEUKEMIA-COOPERATIVE-GROUP AND GIMEMA, British Journal of Haematology, 102(5), 1998, pp. 1344-1353
Authors:
ULUSAKARYA A
MUNCK JN
CASIRAGHI O
KOSCIELNY S
VANTELON JM
DARTEVELLE P
GIRINSKY T
CARDE P
PICO JL
HAYAT M
Citation: A. Ulusakarya et al., LOW SPECIFICITY AND SENSITIVITY OF GA-67 SCAN IN THE EVALUATION OF POST CHEMOTHERAPY MEDIASTINAL RESIDUAL MASSES IN AGGRESSIVE NON-HODGKINS-LYMPHOMA, British Journal of Haematology, 102(1), 1998, pp. 246-246
Authors:
DECAUDIN D
BOSQ J
MUNCK JN
BAYLE C
KOSCIELNY S
BOUDJEMAA S
BENNACEUR A
VENUAT AM
NACCACHE P
BENDAHMANE B
RIBRAG V
CARDE P
PICO JL
HAYAT M
Citation: D. Decaudin et al., MANTLE CELL LYMPHOMAS - CHARACTERISTICS, NATURAL-HISTORY AND PROGNOSTIC FACTORS OF 45 CASES, Leukemia & lymphoma, 26(5-6), 1997, pp. 539
Authors:
CARAYOL G
BOURHIS JH
GUILLARD M
BOSQ J
PAILLER C
CASTAGNA L
VERNANT JP
PICO JL
HAYAT M
CHOUAIB S
CAIGNARD A
Citation: G. Carayol et al., QUANTITATIVE-ANALYSIS OF T-HELPER-1, T-HELPER-2, AND INFLAMMATORY CYTOKINE EXPRESSION IN PATIENTS AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION - RELATIONSHIP WITH THE OCCURRENCE OF ACUTE GRAFT-VERSUS-HOST DISEASE, Transplantation, 63(9), 1997, pp. 1307-1313
Authors:
IBRAHIM A
GAUTIER E
ROITTMANN S
BOURHIS JH
FAJAC A
CHARNOZ I
TERRIER P
SALORD JM
TANCREDE C
HAYAT M
BERNAUDIN JF
PICO JL
Citation: A. Ibrahim et al., SHOULD CYTOMEGALOVIRUS BE TESTED FOR IN BOTH BLOOD AND BRONCHOALVEOLAR LAVAGE FLUID OF PATIENTS AT A HIGH-RISK OF CMV PNEUMONIA AFTER BONE-MARROW TRANSPLANTATION, British Journal of Haematology, 98(1), 1997, pp. 222-227
Authors:
RIBRAG V
NASR F
ELHAJJ M
BENNACEURGRISCELLI A
CORTI C
HAYAT M
CARDE P
BAYLE C
Citation: V. Ribrag et al., CLONAL CD3(-ASSOCIATED WITH B-CELL NHL OR HD AT RELAPSE - REPORT OF 3CASES() LARGE GRANULAR LYMPHOCYTES (LGL) PROLIFERATION), Blood, 90(10), 1997, pp. 3944-3944
Authors:
RIBRAG V
TOUITOU R
BOSQ J
KOSCIELNY S
OUABDESSELAM R
NASR F
CORTI C
BRAULT P
CARDE P
HAYAT M
JOAB I
PALLARDY M
Citation: V. Ribrag et al., HIGH SERUM INTERLEUKIN-2 RECEPTOR AND INTERLEUKIN-6 LEVELS ARE ASSOCIATED WITH A POOR FREEDOM FROM PROGRESSION IN ADULT NON-HODGKINS-LYMPHOMA (NHL), Blood, 90(10), 1997, pp. 3945-3945
Authors:
FENAUX P
CHASTANG C
SANZ M
THOMAS X
DOMBRET H
LINK H
GUERCI A
FEGUEUX N
SANMIGUEL J
RAYON C
ZITTOUN R
GARDIN C
MALOISEL F
FEY M
TRAVADE P
REIFFERS J
STAMATOULAS A
STOPPA AM
CAILLOT D
LEFRERE F
HAYAT M
CASTAIGNE S
CHOMIENNE C
DEGOS L
Citation: P. Fenaux et al., ATRA FOLLOWED BY CHEMOTHERAPY (CT) VS ATRA PLUS CT AND THE ROLE OF MAINTENANCE THERAPY IN NEWLY-DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA (APL) - FIRST INTERIM RESULTS OF APL-93 TRIAL, Blood, 90(10), 1997, pp. 533-533
Authors:
KEATING S
SUCIU S
MANDELLI F
DEWITTE T
WILLEMZE R
ARCHIMBAUD E
HAYAT M
ROTOLI B
LABAR B
RESEGOTTI L
FAZI P
DARDENNE M
ZITTOUN R
Citation: S. Keating et al., AUTOLOGOUS BMT OR PSCT FOR PATIENTS WITH AML IN FIRST CR - A PRELIMINARY-ANALYSIS OF THE AML-10 STUDY OF THE LEUKEMIA COOPERATIVE GROUP (LCG) OF THE EORTC AND GIMEMA, Blood, 90(10), 1997, pp. 1034-1034
Authors:
BONNOTTE B
BURDILES AM
CHEHIMI J
CARAYOL G
PARDOUX C
DIETRICH PY
KUBIN M
BLAY JY
CAIGNARD A
IBRAHIM A
ROBINET E
HAYAT M
PICO JL
BOURHIS JH
CHOUAIB S
Citation: B. Bonnotte et al., SERUM INTERLEUKIN-12 LEVELS IN PATIENTS UNDERGOING ALLOGENEIC OR AUTOLOGOUS BONE-MARROW TRANSPLANTATION, European cytokine network, 7(3), 1996, pp. 389-394
Authors:
DEWITTE T
SUCIU S
SELLESLAG D
LABAR B
ROOZENDAAL K
ZITTOUN R
RIBEIRO M
KURSTJENS R
HAYAT M
DARDENNE M
SOLBU G
MUUS P
Citation: T. Dewitte et al., SALVAGE TREATMENT FOR PRIMARY RESISTANT ACUTE MYELOGENOUS LEUKEMIA CONSISTING OF INTERMEDIATE-DOSE CYTOSINE-ARABINOSIDE AND INTERSPACED CONTINUOUS INFUSIONS OF IDARUBICIN - A PHASE-II STUDY (NO-06901) OF THE EORTC LEUKEMIA COOPERATIVE GROUP, Annals of hematology, 72(3), 1996, pp. 119-124
Authors:
MUNCK JN
DHERMAIN F
KOSCIELNY S
GIRINSKY T
CARDE P
BOSQ J
DECAUDIN D
JULIERON M
COSSET JM
HAYAT M
Citation: Jn. Munck et al., ALTERNATING CHEMOTHERAPY AND RADIOTHERAPY FOR LIMITED-STAGE INTERMEDIATE AND HIGH-GRADE NON-HODGKINS-LYMPHOMAS - LONG-TERM RESULTS FOR 96 PATIENTS WITH TUMORS GREATER-THAN-5 CM, Annals of oncology, 7(9), 1996, pp. 925-931
Authors:
GERHARTZ HH
ZWIERZINA HH
WALTHER J
FENAUX P
HAYAT M
JACOBS A
HOFFBRAND AV
DARDENNE M
SOLBU G
SUCIU S
AMADORI S
WILLEMZE R
Citation: Hh. Gerhartz et al., INTERLEUKIN-3 PLUS LOW-DOSE CYTOSINE-ARABINOSIDE FOR ADVANCED MYELODYSPLASIA - A PILOT-STUDY, Cancer investigation, 14(4), 1996, pp. 299-306